Melvine's AI Analysis # 48 - 🚀 AI Revolution at Merck: Transforming Pharma from Lab to Patient

Merck & Co., a global leader in pharmaceuticals and healthcare, has embraced artificial intelligence (AI) and generative AI (Gen AI) to drive innovation, improve efficiency, and develop new therapies. As the healthcare and pharmaceutical industries evolve, AI is pivotal in transforming drug discovery, manufacturing, patient care, and operational processes. This article delves into Merck's AI initiatives, industry trends, competitor strategies, the expected impact of AI, and the associated challenges and regulatory landscape

Sign up to read this post
Join Now
Previous
Previous

Melvine's AI Analysis # 47 - 🚀 AI and Generative AI at AstraZeneca: Transforming Pharmaceutical Innovation

Next
Next

Closing Our Series of Posts on AI in the Pharmaceuticals Industry